Leuprorelin increases bodyfat in men with prostate cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1330, 2002-01, pp. : 21-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ADT in prostate cancer increases diabetes and fractures, but not MI

Reactions Weekly, Vol. 1, Iss. 1261, 2009-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

PADT may not survive for elderly men with prostate cancer

Inpharma, Vol. 1, Iss. 1646, 2008-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

FLt3 ligand increases dendritic cell count in prostate cancer

Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Leuprorelin depot not inferior to chemo for nodal breast cancer

Inpharma, Vol. 1, Iss. 1595, 2007-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Association of very low prostate-specific antigen levels with increased cancer-specific death in men with high-grade prostate cancer

By Mahal Brandon A. Aizer Ayal A. Efstathiou Jason A. Nguyen Paul L.

Cancer, Vol. 122, Iss. 1, 2016-01 ,pp. : 78-83

Blackwell Publishing

Access to resources Recommend Favorite